3 min read
Veristat has experience in preparing more than 120 marketing applications. Our exposure to in creating new drug applications (NDAs) and marketing authorization applications (MAAs) has taught us two main lessons:
3 min read
When database locks are delayed, or regulatory agencies request additional analyses for new drug applications (NDAs) or marketing authorization applications (MAAs), it seems there is no alternative but to take a hit to the timeline — or is there?
2 min read
When a team faces multiple submissions in a short timeframe or even simultaneous submissions, uncertainty over timeline organization and the best way to utilize medical writers can be paralyzing.
3 min read
With the summer in full swing, vacations and long weekends by the pool are top of mind.
Although we all have the best intentions to use our paid time off each year, it is also not a secret that Americans are truly terrible at taking time off. According...
2 min read
No two New Drug Applications (NDAs) or Marketing Authorization Applications (MAAs) are the same. However, they all have common aspects that create the opportunity for streamlined operational tips.
3 min read
2 min read
Why would anyone go through the trouble of getting the supplies and putting in the effort to attempt a job well done if they couldn’t see their progress along the way? Just the same,...
1 min read
CYCLE FOR SURVIVAL 2018Every dollar represents hope, strength, and a lasting impact! |
2 min read
With the holiday season in full swing, it’s hard not to reflect on this past year and realize how thankful Veristat is to play such an instrumental role in the world of clinical research.
2 min read
Veristat aspires to make a difference, every day!
As the weather gets colder and we find ourselves in the holiday season, the employees of Veristat decided to make a difference by helping others in their local communities.